Background: Inflammation can be grouped into three phases: proinflammatory, anti-inflammatory, and resolution. The latter, mainly attributed to lipid mediators, is the most recently described, and has been studied little in coronary ischemic diseases. Objective: To evaluate 1) if acute coronary syndromes (ACS) manifest different circulating levels of resolution mediators compared with stable angina (SA); 2) if their concentrations are related to those of pro and anti-inflammatory mediators; and 3) if such concentrations are associated with the severity of the disease and the damage produced. Method: LTB4, RvD1, LXA4, ET-1, MMP-2, MMP-9, TIMP-1, IL-1β, IL-6, IL-8 and IL-10 were measured in serum. The GRACE score was established as parameter of gravity, and LVEF as a damage parameter. Results: Thirty patients with SA, 37 with NEST-ACS, 38 with STEMI, and 10 individuals with non-cardiogenic chest pain were included. Patients with coronary artery disease showed elevated levels of inflammatory cytokines and low levels of resolution mediators. Conclusions: The low resolution response even in patients with acute coronary disease suggests an inability to repair damage. Testing this hypothesis would have the potential to suggest new therapies for the management of chronic cardiovascular inflammation.
CITATION STYLE
Villar, R. S. D., Ortega-Hernández, J. A., Pérez, L. F., Sánchez-Muñoz, F., Martínez, J. C. A., González-Pacheco, H., & Bojalil, R. (2018). Los niveles de mediadores prorresolutivos no corresponden con los de mediadores inflamatorios en enfermedades isquémicas coronarias. Gaceta Medica de Mexico, 154, S9–S14. https://doi.org/10.24875/GMM.18004572
Mendeley helps you to discover research relevant for your work.